Dr. Brian Wolpin, director of @DanaFarber_Hale and a principal investigator of the daraxonrasib trial, discusses with @BostonGlobe what the results could mean for patients. @DanaFarber
The Boston Globe (@BostonGlobe) profile pictureThe Boston Globe
@BostonGlobeAug 17
A new pancreatic cancer drug has been hailed as a breakthrough treatment that could double the life expectancy of people with the infamously lethal cancer. trib.al/SFyTidE
Patients receive ‘historic’ pill for deadly pancreatic cancer - The Boston Globe

Patients receive ‘historic’ pill for deadly pancreatic cancer - The Boston Globe

Daraxonrasib, which is awaiting FDA approval, could double the life expectancy of people with advanced disease.

bostonglobe.com

Aug 17, 2026 · 8:12 PM UTC

6
32
3,486